У нас вы можете посмотреть бесплатно Access to visceral leishmaniasis diagnostics & impact towards attaining elimination targets in Kenya или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
In this presentation “Access to visceral leishmaniasis diagnostics and impact towards attaining the elimination targets in Kenya”, Dr Dziedzom Komi de Souza (Senior Scientific Officer, NTD programme, Foundation for Innovative New Diagnostics, FIND) outlines the barriers and successes in increasing access to visceral leishmaniasis diagnostics in Kenya. This presentation is part of the following session at the seventh annual ISNTD d3 conference on diagnostics, drug discovery and development for tropical diseases organised by the International Society for Neglected Tropical Diseases: “Essential diagnostics for neglected tropical diseases: from technology to access, for disease elimination” (full recording: • Essential diagnostics for neglected t... ), with the following presentations and speakers: "Launch of the World Health Organisation's third Essential Diagnostics List" Dr Francis Moussy (Secretary, SAGE IVD and Essential Diagnostic List, World Health Organisation) - • World Health Organisation's third Ess... "Access to visceral leishmaniasis diagnostics and impact towards attaining the elimination targets in Kenya" Dr Dziedzom Komi de Souza (Senior Scientific Officer, NTD programme, Foundation for Innovative New Diagnostics, FIND) - • Access to visceral leishmaniasis diag... "Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection; a modelling study" Dr Jessica Clark (University of Glasgow) - • Egg- and antigen-based estimates of S... "Schistosoma eggs, circulating antigens or DNA? What do these different diagnostic markers reveal when monitoring praziquantel treatment in a clinical trial?" Dr Pytsje Hoekstra (Leiden University Medical Center, the Netherlands) - • Schistosoma eggs, circulating antigen... Recorded as part of the ISNTD d3 2021 conference on February 25th 2021, online. https://www.isntd.org/isntd-d3